5138 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 103 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ITGADIntegrin, alpha DCD markers
Predicted membrane proteins
Tissue enriched
ITGAEIntegrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)CD markers
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGAMIntegrin, alpha M (complement component 3 receptor 3 subunit)Cancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGAVIntegrin, alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Focal adhesion sites
Cytosol
Expressed in all
ITGAXIntegrin, alpha X (complement component 3 receptor 4 subunit)CD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites
Expressed in all
ITGB2Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolExpressed in all
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB4Integrin, beta 4Cancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
Cell Junctions
Mixed
ITGB5Integrin, beta 5Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Mitochondria
Expressed in all
ITGB6Integrin, beta 6Cancer-related genes
Disease related genes
Plasma proteins
Predicted membrane proteins
Nucleoplasm
Cell Junctions
Centrosome
Tissue enhanced
ITGB7Integrin, beta 7Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Mixed
ITGB8Integrin, beta 8Cancer-related genes
Predicted membrane proteins
Plasma membrane
Cytosol
Mixed
ITM2AIntegral membrane protein 2APredicted intracellular proteins
Predicted membrane proteins
NucleoplasmExpressed in all
ITM2BIntegral membrane protein 2BDisease related genes
Predicted membrane proteins
Golgi apparatus
Vesicles
Expressed in all
ITPR1Inositol 1,4,5-trisphosphate receptor, type 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
ITPR2Inositol 1,4,5-trisphosphate receptor, type 2Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Endoplasmic reticulum
Mixed
ITPR3Inositol 1,4,5-trisphosphate receptor, type 3Plasma proteins
Predicted membrane proteins
VesiclesMixed
ITPRIPInositol 1,4,5-trisphosphate receptor interacting proteinPredicted membrane proteins
VesiclesExpressed in all
ITPRIPL1Inositol 1,4,5-trisphosphate receptor interacting protein-like 1Predicted membrane proteins
Tissue enriched
ITPRIPL2Inositol 1,4,5-trisphosphate receptor interacting protein-like 2Predicted intracellular proteins
Predicted membrane proteins
CentrosomeExpressed in all
IYDIodotyrosine deiodinaseDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Plasma membraneTissue enriched
IZUMO1Izumo sperm-egg fusion 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
IZUMO2IZUMO family member 2Predicted membrane proteins
Transporters
Tissue enriched
JAG1Jagged 1CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatus
Plasma membrane
Expressed in all
JAG2Jagged 2Predicted membrane proteins
VesiclesTissue enhanced
JAGN1Jagunal homolog 1Disease related genes
Predicted membrane proteins
VesiclesExpressed in all
JAKMIP1Janus kinase and microtubule interacting protein 1Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
JAKMIP2Janus kinase and microtubule interacting protein 2Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatusTissue enriched
JAKMIP3Janus kinase and microtubule interacting protein 3Predicted membrane proteins
Tissue enhanced
JAM2Junctional adhesion molecule 2CD markers
Predicted membrane proteins
CytosolTissue enhanced
JAM3Junctional adhesion molecule 3Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatusExpressed in all
JKAMPJNK1/MAPK8-associated membrane proteinCancer-related genes
Predicted membrane proteins
Nucleoplasm
Vesicles
Expressed in all
JPH1Junctophilin 1Predicted membrane proteins
NucleusTissue enriched
JPH2Junctophilin 2Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
JPH3Junctophilin 3Disease related genes
Predicted membrane proteins
Nucleoplasm
Cytosol
Tissue enriched
JPH4Junctophilin 4Predicted membrane proteins
Nucleoplasm
Golgi apparatus
Tissue enhanced
JTBJumping translocation breakpointCancer-related genes
Plasma proteins
Predicted membrane proteins
Vesicles
Actin filaments
Expressed in all
KALRNKalirin, RhoGEF kinaseCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cytosol
Tissue enhanced
KANSL1LKAT8 regulatory NSL complex subunit 1-likePredicted intracellular proteins
Predicted membrane proteins
CytosolTissue enriched
KAZALD1Kazal-type serine peptidase inhibitor domain 1Predicted secreted proteins
Tissue enhanced
KCNA1Potassium channel, voltage gated shaker related subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium channel, voltage gated shaker related subfamily A, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNA2Potassium channel, voltage gated shaker related subfamily A, member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium channel, voltage gated shaker related subfamily A, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium channel, voltage gated shaker related subfamily A, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium channel, voltage gated shaker related subfamily A, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium channel, voltage gated Shab related subfamily B, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced

« prev | Page of 103 | next »